首页> 外国专利> System and Method for Preventing Bacterial and fungal infections that include urinary tract infections (UTIs) using N - Halogenated amino acids

System and Method for Preventing Bacterial and fungal infections that include urinary tract infections (UTIs) using N - Halogenated amino acids

机译:使用N-卤代氨基酸预防细菌和真菌感染(包括尿路感染(UTI))的系统和方法

摘要

It reveals a system that prevents the development of infection and the establishment of a Biofilm on Medical Devices in general and, in particular, urinary tract infections (UTIs), which include a catheter associated urinary tract infections (ituac).The system includes a Medical Device (such as a catheter) and an antimicrobial composition containing an antimicrobial Compound. A Medical Device manages the composition of both the Inner and Outer portions of the device, as well as the inside of the bladder and the Urethra itself.The reduction or elimination of the infection can be achieved by Irrigation of the medical device, through the bathroom of the bladder, or by Irrigation of bladder with composition.Claim 1: a system of antimicrobial Treatment comprises (a) a Medical Device implantation or for insertion in a patient at risk of, or affected by, a microbial infection; and (b) an aqueous antimicrobial composition comprising a composition comprising (1) A C And effective for antimicrobial use at least one amino acid n - Halogenated,A derivative thereof or a Derivative of the amino acid n - a source of halogen or Halogenated amino acid n - or mixtures thereof; (2) and optionally at least one type of Halide Salt selected from the group consisting of Sodium Chloride, Sodium bromide, potassium chloride, POTASSIUM BROMIDE, CL Oruro MagnesiumMAGNESIUM BROMIDE and mixtures thereof; Halide Salt concentration ranging from 0.05 to about 20 g / l, preferably from about 2 to 20 g / l, more preference of about 4 to about 20 g / l aqueous composition; (3) a pH of about 2 to about Share 8; and (4) optionally, an effective amount of HOBr or HOCl for antimicrobial use.Or a source or composition capable of releasing HOBr or HOCl (5); and optionally a constituent selected from the group consisting of pH adjusting agents, chelating agents, calcium and magnesium, acids and / Or Biologically acceptable salts thereof which are compatible with the system. Attachment antimicrobialAnd mixtures thereof to keep the PH in the range of between approximately 2 and 8.
机译:它揭示了一种系统,该系统可防止感染的发展以及一般情况下在医疗器械上特别是尿道感染(UTI)(包括与导管相关的尿路感染(ituac))上的生物膜的形成。装置(例如导管)和包含抗菌化合物的抗菌组合物。医疗设备管理设备内部和外部的组成以及膀胱内部和尿道口本身。通过减少对医疗设备的灌溉,可以通过浴室来减少或消除感染权利要求1:一种抗微生物治疗系统包括:(a)医疗器械植入或用于将其插入有微生物感染风险或受其影响的患者中; (b)水性抗菌组合物,其包含包含以下成分的组合物:(1)AC且对于抗菌用途有效,至少一种氨基酸n-卤代,其衍生物或该氨基酸的衍生物n-卤素或卤代氨基酸的来源n-或其混合物; (2)和任选地选自由氯化钠,溴化钠,氯化钾,溴化钾,CL Oruro镁镁溴化镁及其混合物组成的组中的至少一种卤化物盐;卤化物盐浓度为0.05至约20g / l,优选约2至20g / l,更优选约4至约20g / l的水性组合物; (3)pH为约2至约Share 8; (4)任选地,有效量的用于抗菌的HOBr或HOCl。或能够释放HOBr或HOCl的来源或组合物(5);和以及任选地选自与系统相容的pH调节剂,螯合剂,钙和镁,酸和/或它们的生物学上可接受的盐的成分。附着抗菌剂及其混合物以使PH保持在大约2到8之间。

著录项

  • 公开/公告号AR055679A1

    专利类型

  • 公开/公告日2007-08-29

    原文格式PDF

  • 申请/专利权人 NOVACAL PHARMACEUTICALS INC.;

    申请/专利号AR2006P104395

  • 发明设计人

    申请日2006-10-05

  • 分类号A61K31/185;A61K31/198;A61K33/00;A61K33/14;A61K33/20;A61L29/16;A61P31/04;A61P31/10;

  • 国家 AR

  • 入库时间 2022-08-21 20:59:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号